FDA 483 - Genzyme Corporation - February 14, 2025
FDA 483 for Genzyme Corporation on February 14, 2025. Product: biologics. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA 483 for Genzyme Corporation on February 14, 2025. Product: biologics. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Genzyme CorporationInspection Date
February 14, 2025
Product Type
biologics
ID: a439a63d-4758-43cc-a498-3dd9bdfb7f22
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox